Radiant Biotherapeutics Announces Poster Presentation at 2025 American Association for Cancer Research (AACR) Annual Meeting ...

today announced that an abstract has been accepted for poster presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 30 to June 3, 2025 in Chicago ...

The AAAS Student E-poster competition recognizes the individual efforts of students who are actively working toward an undergraduate, graduate or doctoral-level degree. The winners’ presentations ...

The full abstract will be available on the ASCO® website on May 22, 2025, at 5:00 p.m. ET.

Employers must abide by federal and state requirements to prominently display labor law compliance posters in workplaces.

To overcome these limitations, Antengene developed ATG-201, a “2+1” CD19 x CD3 TCE, which was evaluated in a series of in ...

These data will be presented at the American Association of Cancer Research (AACR) Annual Meeting from April 25 to 30, 2025 in Chicago, Illinois (USA). In collaboration with the National Cancer ...

(Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other tumor types, today ...

Enliven is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics to help people not only live longer, but live better. Enliven aims to ...

Two additional abstracts related to AFM24 and its combination with atezolizumab have also been accepted for poster presentations at the ASCO Annual Meeting, showcasing the company's ongoing ...

You do not need to pay membership dues to create an ESA member account or submit for the meeting. We invite submission of abstracts for latebreaking and project proposed posters for the 2025 ESA ...